Research Progress of Illegally Added Chemical Medicines and Detection in Chinese Patent Medicines and Health Foods for Regulating Three-Hypers
-
摘要: 高血糖、高血压、高血脂统称为"三高症", 现在已经成为威胁人们身体健康的常见疾病. 具有调节"三高症"作用的保健食品和中成药越来越频繁地应用于此类疾病的日常预防及治疗. 然而有不法分子为谋取利益, 向其中违规添加化学药物, 对患者造成安全隐患. 针对调节"三高症"的中成药和保健食品中非法添加化学药物的种类进行了总结, 并对此类非法添加药物的国家标准补充检验方法及其他学者的检测分析方法研究情况进行了综述, 最后根据目前非法添加现状分析了进一步的研究方向, 以期为非法添加检测工作提供参考.Abstract: Hyperglycemia, hypertension and hyperlipemia, collectively known as the "three-hypers", have already become the common diseases that threaten people's health. Chinese patent medicines and health food are more and more frequently used in the daily prevention and treatment of these diseases. However, some chemical substances have been illegally added for profit, causing safety hazards to patients. The types of illegally added chemical medicines in Chinese patent medicines and health foods that regulate "three-hypers" in recent years were summarized, and the research situation of the national standard supplementary testing methods and other analysis methods for these of illegally added medicines were introduced. Finally, according to the current situation of illegal addition, further research directions are analyzed in order to provide reference for the detection on illegal addition.
-
Key words:
- three-hypers /
- illegal medicines addition /
- Chinese patent medicine /
- health food
-
表 1 降血压类代表性化学药物
Table 1. Typical chemical medicines for antihypertensive
药物类型 代表性化学药物 利尿剂 氢氯噻嗪、螺内酯、吲达帕胺、呋塞米 β受体阻滞剂 美托洛尔、卡维地洛、比索洛尔、阿替洛尔、普萘洛尔 α受体阻滞剂 哌唑嗪、特拉唑嗪、布那唑嗪、多沙唑嗪、妥拉唑林、甲磺酸酚妥拉明 钙拮抗剂 硝苯地平、氨氯地平、乐卡地平、尼莫地平、尼卡地平、尼群地平、尼索地平、非洛地平、贝尼地平、拉西地平、维拉帕米、地尔硫卓、氟桂利嗪、桂利嗪、利多氟嗪 血管紧张素转换酶抑制剂 卡托普利、依那普利、赖诺普利、培哚普利、雷米普利、贝那普利、咪达普利、福辛普利 血管紧张素受体拮抗剂 氯沙坦、缬沙坦、厄贝沙坦、坎地沙坦酯、他索沙坦、依普罗沙坦、替米沙坦 交感神经抑制剂 可乐定、利血平、甲基多巴 表 2 降血脂类代表性化学药物
Table 2. Typical chemical medicines for lipid-lowering
药物类型 代表性化学药物 他汀类 洛伐他汀、阿托伐他汀、瑞舒伐他汀、匹伐他汀、辛伐他汀、普伐他汀 贝特类 非诺贝特、苯扎贝特、吉非贝齐、氯贝特 胆固醇吸收抑制剂类 依折麦布 烟酸类 阿西莫司、普罗布考 表 3 降血糖类代表性化学药物
Table 3. Typical chemical medicines for anti-diabetic
药物类型 代表性化学药物 磺酰脲类 甲苯磺丁脲、格列本脲、格列齐特、格列吡嗪、格列美脲、格列喹酮、格列波脲、氯磺丙脲、妥拉磺脲 非磺酰脲类 瑞格列奈、那格列奈、米格列奈 双胍类 二甲双胍、苯乙双胍、丁二胍 α-葡萄糖苷酶抑制剂 阿卡波糖、伏格列波糖 胰岛素增敏剂 罗格列酮、吡格列酮 二肽基肽酶-4抑制剂 西格列汀、阿格列汀、维格列汀、利格列汀、沙格列汀 GLP-1受体激动剂 艾塞那肽、贝拉鲁肽、利拉鲁肽、洛塞那肽 醛糖还原酶抑制剂 依帕司他 表 4 国家批准补充检验方法涉及的非法添加化学药物及其分析条件
Table 4. Illegal additional chemical medicines and chromatographic analytical conditions involved in nation approved supplementary test method
批准件号 药品名称 检测化学药物成分 色谱分析条件 2009032 降压类中成药 阿替洛尔、盐酸可乐定、氢氯噻嗪、卡托普利、哌唑嗪、利血平、硝苯地平 C18柱(4.6 mm×250 mm,5 μm);流动相:乙腈-0.2%磷酸,梯度洗脱;流速1.0 mL/min;进样量10 μL;柱温35 ℃;检测波长220 nm [13]. 2014008 降压类中成药和辅助降血压类保健食品 氨氯地平、硝苯地平、尼群地平、尼莫地平、尼索地平、非洛地平 C18柱(4.6 mm×250 mm,5 μm);流动相:乙腈-0.2%磷酸,梯度洗脱;进样量10 μL;检测波长220 nm [14]. 2009029 降糖类中成药 (1)甲苯磺丁脲、格列本脲、格列齐特、格列吡嗪、格列喹酮、格列美脲、马来酸罗格列酮、瑞格列奈、盐酸吡格列酮;(2)盐酸二甲双胍、盐酸苯乙双胍 (1)C18柱(4.6 mm×250 mm,5 μm);流动相:甲醇-0.01 mol/L乙酸铵,梯度洗脱;进样量10 μL;检测波长235 nm;(2)C18柱(4.6 mm×250 mm,5 μm);流动相:甲醇-庚烷磺酸钠溶液,梯度洗脱;进样量5 μL;检测波长235 nm [15]. 2011008 降糖类中成药 盐酸丁二胍 C18柱(4.6 mm×250 mm,5 μm);流动相:甲醇-庚烷磺酸钠溶液,梯度洗脱;流速1.0 mL/min;进样量10 μL;柱温35 ℃;检测波长235 nm [16]. 2013001 降糖类中成药和保健食品 格列波脲 C18柱(4.6 mm×250 mm,5 μm);流动相:甲醇-0.01 mol/L乙酸铵,梯度洗脱;进样量10 μL;检测波长235 nm [17]. 食药监办许2010[114号] 辅助降血脂类保健食品 洛伐他汀、辛伐他汀、烟酸 C18柱;流动相:甲醇-20 mmol/L乙酸铵,梯度洗脱;流速1.0 mL/min;进样量10 μL;柱温35 ℃;进样量10 μL;检测波长235 nm [14]. 表 5 已发布研究成果涉及的非法添加化学药物及其分析条件
Table 5. Illegal additional chemical medicines and analytical conditions involved in published studies
成分作用 分析方法 检测化学药物成分 色谱分析条件 降血压 HPLC-DAD定量分析LC-MS/MS定性确证 阿替洛尔、卡托普利、氢氯噻嗪、盐酸普萘洛尔、氨苯蝶啶、硝苯地平、苯磺酸左旋氨氯地平、利血平、氯沙坦钾、替米沙坦、尼莫地平、尼群地平、坎地沙坦酯、缬沙坦、盐酸可乐定、甲磺酸多沙唑嗪、吲达帕胺、尼索地平、盐酸哌唑嗪、富马酸比索洛尔、非洛地平 Agilent Poroshell 120 Phenyl-Hexyl(100 mm×2.1 mm,2.7 μm);流动相:A为甲醇∶乙腈(2∶1),B为甲酸水溶液(pH值为2.5±0.1),梯度洗脱;流速0.8 mL/min;柱温40 ℃;进样量10 μL;检测波长215、270、350 nm [26]. LC-QTOF/MS 贝那普利、盐酸贝那普利、硝苯地平、尼群地平、尼莫地平、吲达帕胺、氯沙坦钾、缬沙坦、坎地沙坦酯、酒石酸美托洛尔、卡维地洛、盐酸普萘洛尔、阿替洛尔、利血平、盐酸哌唑嗪、甲磺酸多沙唑嗪、盐酸特拉唑嗪、盐酸妥拉唑林 Agilent Eclipse plus C18(50 mm×2.1 mm,1.8 μm);流动相:0.5%甲酸水溶液-乙腈,梯度洗脱;流速0.2 mL/min;进样量1 μL;柱温30 ℃ [33]. 降血脂 UPLC-DAD 阿托伐他汀钙、苯扎贝特、非诺贝特、氟伐他汀钠、吉非罗齐、洛伐他汀、去羟基洛伐他汀、洛伐他汀羟酸钠、辛伐他汀、美伐他汀、普伐他汀钠、罗苏伐他汀钠 AgilentPoroshell 120 EC-C18(4.6 mm×100 mm,2.7 μm);流动相:0.02 mol/L乙酸铵-甲醇,梯度洗脱;流速1.0 mL/min;进样量5 μL;柱温30 ℃;检测波长230 nm [25]. 降血糖 TLC 格列本脲、格列美脲、格列吡嗪、格列齐特、格列喹酮 GF 254薄层板,展开剂为氯仿∶环已烷∶乙醇∶冰醋酸(8∶12∶1∶1) [19]. TLC 二甲双胍、苯乙双胍 GF 254薄层板,展开剂为石油醚∶甲醇∶冰乙酸(5∶12∶0.5) [20]. HPLC-UV 二甲双胍、格列吡嗪、格列本脲、格列美脲 Shim-Pack VP-ODS柱(4.6 mm×250 mm,4.6 μm);流动相:甲醇-0.02 mol/L磷酸二氢铵水溶液(pH值调节至3.0),梯度洗脱;流速1.0 mL/min;进样量20 μL;柱温25 ℃;检测波长230 nm [22]. HPLC-DAD 阿卡波糖、盐酸二甲双胍、盐酸丁二胍、盐酸苯乙双胍、甲苯磺丁脲、妥拉磺脲、格列吡嗪、格列齐特、马来酸罗格列酮、格列波脲、盐酸吡格列酮、格列本脲、格列美脲、那格列奈、格列喹酮、瑞格列奈 C18柱(250 mm×4.6 mm,5 μm);流动相:甲醇-0.01 mol/L乙酸铵溶液,梯度洗脱;流速1.0 mL/min;进样量10 μL;柱温30 ℃;检测波长210、235 nm [23]. HPLC-DAD 盐酸二甲双胍、盐酸丁二胍、盐酸苯乙双胍、格列吡嗪、格列齐特、马来酸罗格列酮、盐酸吡格列酮、格列本脲、格列美脲、格列喹酮、瑞格列奈、格列波脲、甲苯磺丁脲 Agilent Zorbax SB-C18(150 mm×2.1 mm,1.8 μm);流动相:0.02 mol/L乙酸铵溶液-乙腈,梯度洗脱;流速0.2 mL/min;进样量2 μL;柱温35 ℃;检测波长235 nm,210~400 nm [24]. HPLC-DAD定量分析LC-MS/MS定性确证 甲苯磺丁脲、格列本脲、格列齐特、格列吡嗪、格列喹酮、格列美脲、马来酸罗格列酮、瑞格列奈、盐酸吡格列酮 岛津Wondasil C18-WR色谱柱(4.6 mm×250 mm,5 μm);流动相:甲醇-0.01 mol/L乙酸铵溶液,梯度洗脱;流速1.0 mL/min;柱温35 ℃;检测波长235 nm [27]. LC-MS/MS 盐酸二甲双胍、盐酸苯乙双胍、盐酸罗格列酮、格列吡嗪、盐酸吡格列酮、格列齐特、格列波脲、格列本脲、格列美脲、格列喹酮、瑞格列奈、盐酸丁二胍、甲苯磺丁脲 岛津Inertsil ODS-SP色谱柱(150 mm×2.1 mm,5 μm);流动相:10 mmol/L乙酸铵+0.1%甲酸水溶液-甲醇,梯度洗脱;流速0.2 mL/min;进样量10 μL;柱温35 ℃ [28]. LC-MS/MS 二甲双胍、苯乙双胍、罗格列酮、格列苯脲 Thermo BDSHypersil C8(2.1 mm×100 mm,2.4 μm);流动相:A为0.2%甲酸水溶液,B为乙腈∶甲醇(6∶4),梯度洗脱;流速0.3 mL/min;进样量5 μL;柱温30 ℃ [29]. UPLC-MS/MS 瑞格列奈、那格列奈、米格列奈、格列吡嗪、格列苯脲、格列美脲、格列喹酮、二甲双胍、甲苯磺丁脲、格列波脲、吡格列酮、吡咯齐特、苯乙双胍、罗格列酮 Agilent SB AQ柱(2.1 mm×100 mm,3.0 μm);流动相:0.1%甲酸溶液-乙腈,梯度洗脱;流速:0.3 mL/min;进样量10 μL;柱温30 ℃ [31]. LC-QTOF/MS 盐酸二甲双胍、盐酸丁二胍、盐酸苯乙双胍、马来酸罗格列酮、盐酸吡格列酮、格列吡嗪、甲苯磺丁脲、瑞格列奈、格列齐特、格列波脲、格列本脲、那格列奈、格列美脲、格列喹酮 Thermo syncronis-C18色谱柱(150 mm×4.6 mm,5 μm);流动相:0.1%甲酸水溶液-乙腈,梯度洗脱;流速0.3 mL/min;进样量5 μL;柱温30 ℃ [34]. 超高效液相色谱-静电场轨道肼高分辨质谱 西布曲明、格列本脲、尼莫地平等73种化学药物 WatersAcquity HSS T3 C18(2.1 mm×100 mm,1.8 μm);流动相:乙腈-0.1%甲酸,梯度洗脱;流速:0.3 mL/min;进样量5 μL;柱温35 ℃ [35]. 降血脂、降血糖 LC-MS/MS 苯扎贝特、阿托伐他汀钙、吉非贝齐、洛伐他汀、辛伐他汀、非诺贝特、二甲双胍、苯乙双胍、阿卡波糖、吡格列酮、格列吡嗪、瑞格列奈、格列齐特、格列本脲、格列美脲、格列喹酮 C18柱(2.1 mm×150 mm,5 μm);流速0.3 mL/min;进样量1 μL;柱温30 ℃. 流动相A(测定l-7):20 mol/L醋酸铵溶液-乙腈,流动相B(测定8、9):0.5%甲酸溶液-乙腈,流动相C(测定10-17):0.5%甲酸溶液-乙腈[30]. 降血糖、降血脂、降血压 LC-MS/MS 格列本脲、盐酸二甲双胍、马来酸罗格列酮、盐酸苯乙双胍、格列齐特、甲苯磺丁脲、格列美脲、格列喹酮、瑞格列奈、格列波脲、盐酸吡格列酮、盐酸丁二胍、洛伐他汀、烟酸、辛伐他汀、美伐他汀、盐酸哌唑嗪、氢氯噻嗪、硝苯地平、卡托普利、盐酸可乐定、尼索地平、马来酸氨氯地平、尼莫地平、那格列奈、氯磺丙脲、氟伐他汀钠、苯扎贝特、非诺贝特、盐酸普萘洛尔、盐酸维拉帕米、米诺地尔、酒石酸美托洛尔、厄贝沙坦、布美他尼、盐酸尼卡地平、盐酸特拉唑嗪、富马酸比索洛尔、替米沙坦、格列吡嗪、阿替洛尔、利血平、非洛地平、尼群地平、去羟基洛伐他汀 Agilent Eclipse Plus C18柱(2.1 mm×100 mm,1.8 μm);流动相:5 mmol/L乙酸铵溶液(用甲酸调节pH值至3.0)-乙腈,梯度洗脱;流速:0.2 mL/min;进样量1 μL;柱温35 ℃ [32]. -
[1] 吴斌, 秦舟, 徐珽. 老年高血压患者口服一线降血压药物利用分析: 全国多中心研究[J]. 医药导报, 2020, 39(2): 156-160. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202002007.htmWU Bin, QIN Zhou, XU Ting. Analysis of the use of the first-line antihypertensive agents in senile patients with hypertension: a national multicenter study[J]. Herald of Medicine, 2020, 39(2): 156-160. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202002007.htm [2] 程凤娟. 降血糖药物的使用现状分析[J]. 基层医学论坛, 2018, 22(8): 1115-1116. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLT201808073.htm [3] 胡静. 降血脂药物的临床使用情况和合理用药分析[J]. 中国药物与临床, 2020, 20(12): 2044-2045. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC202012066.htmHU Jing. Analysis of the clinical and rational use of the lipid-lowering drugs[J]. Chinese Remedies & Clinics, 2020, 20(12): 2044-2045. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC202012066.htm [4] 曹晓霞. 口服降血糖药物的不良反应及合理应用[J]. 人人健康, 2019, 16: 189. https://www.cnki.com.cn/Article/CJFDTOTAL-RRJK201916229.htmCAO Xiao-xia. Adverse effects and rational use of oral hypoglycemic drugs[J]. Health Everyone, 2019, 16: 189. https://www.cnki.com.cn/Article/CJFDTOTAL-RRJK201916229.htm [5] 张小龙, 王昆, 吴先富, 马玲云, 肖新月. 中药及保健食品中非法添加状况分析[J]. 中国药师, 2014, 17(10): 1749-1753. doi: 10.3969/j.issn.1008-049X.2014.10.048ZHANG Xiao-long, WANG Kun, WU Xian-fu, MA Ling-yun, XIAO Xin-yue. Analysis on chemical substances illegally added in TCM and health products[J]. China Pharmacist, 2014, 17(10): 1749-1753. doi: 10.3969/j.issn.1008-049X.2014.10.048 [6] 李梦怡, 吴迪, 董喆, 董亚蕾, 曹进. HPLC-Q-TOF/MS法快速筛查及定量分析辅助降血压类保健食品中的15种非法添加药物[J]. 药物分析杂志, 2020, 40(2): 260-267. https://www.cnki.com.cn/Article/CJFDTOTAL-YWFX202002010.htmLI Meng-yi, WU Di, DONG Zhe, DONG Ya-lei, CAO Jin. Rapid screening and quantitative detection of 15 illegally added drugs in antihypertensive health foods by HPLC-Q-TOF/MS[J]. Chinese Journal of Pharmaceutical Analysis, 2020, 40(2): 260-267. https://www.cnki.com.cn/Article/CJFDTOTAL-YWFX202002010.htm [7] 白雪, 李锋武, 李卓, 王芍, 艾芸, 李尔春. 降糖类中成药和保健食品中非法添加化学药物检测技术的研究进展[J]. 华西药学杂志, 2020, 35(3): 338-341. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYO202003023.htmBAI Xue, LI Feng-wu, LI Zhuo, WANG Shao, AI Yun, LI Er-chun. Research advances on the detection technology of illegally adulterated chemical substances in antidiabetic proprietary Chinese medicines and health food[J]. West China Journal of Pharmaceutical Sciences, 2020, 35(3): 338-341. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYO202003023.htm [8] 谭莹, 胡斌, 姚鹏程, 张金铎. 中成药中添加非法化学药品的情况调查[J]. 中国卫生产业, 2017, 19: 178-179. https://www.cnki.com.cn/Article/CJFDTOTAL-WSCY201719080.htmTAN Ying, HU Bin, YAO Peng-cheng, ZHANG Jin-duo. Investigation on status of chemicals illegally added into Chinese patent medicines[J]. China Health Industry, 2017, 19: 178-179. https://www.cnki.com.cn/Article/CJFDTOTAL-WSCY201719080.htm [9] 田俏, 荣阳, 荣根满. 常用降血压药物的新认识及合理应用与药学研究[J]. 中国医药指南, 2019, 17(6): 295-296. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK201906251.htmTIAN Qiao, RONG Yang, RONG Gen-man. New understanding on rational application and pharmacological study of commonly used blood-lowering drugs[J]. Guide of China Medicine, 2019, 17(6): 295-296. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK201906251.htm [10] 钮正睿, 王聪, 曹进. 保健食品中非法添加药物种类及其检测方法研究进展[J]. 食品安全质量检测学报, 2019, 10(18): 6131-6142. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAJ201918031.htmNIU Zheng-rui, WANG Cong, CAO Jin. Research advances on types of illegally added drugs and their detection methods in health foods[J]. Journal of Food Safety & Quality, 2019, 10(18): 6131-6142. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAJ201918031.htm [11] 董玲玲. 糖尿病药物的分类及特点[J]. 基层医学论坛, 2013, 17(8): 1044-1045. doi: 10.3969/j.issn.1672-1721.2013.08.071DONG Ling-ling. Classification and characteristics of antidiabetic drugs[J]. The Medical Forum, 2013, 17(8): 1044-1045. doi: 10.3969/j.issn.1672-1721.2013.08.071 [12] 姜建国, 张西如, 张轶华, 宋更申. LC-MS/MS多反应监测快速识别抗感冒药中15种有效成分[J]. 药学学报, 2013, 48(1): 94-97. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXB201301018.htmJIANG Jian-guo, ZHANG Xi-ru, ZHANG Yi-hua, SONG Geng-shen. Rapid identification 15 effective components of anti common cold medicine with MRM by LC-MS/MS[J]. Acta Pharmaceutica Sinica, 2013, 48(1): 94-97. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXB201301018.htm [13] 国家食品药品监督管理局. 药品检验补充方法和检验项目批准件. 批准件编号2009032降压类中成药[S]. 2009. [14] 国家食品药品监督管理局. 药品检验补充方法和检验项目批准件. 批准件编号2014008降压类中成药和辅助降血压类保健食品[S]. 2014. [15] 国家食品药品监督管理局. 药品检验补充方法和检验项目批准件. 批准件编号2009029降糖类中药[S]. 2009. [16] 国家食品药品监督管理局. 药品检验补充方法和检验项目批准件. 批准件编号2011008降糖类中成药中非法添加盐酸丁二胍补充检验方法[S]. 2011. [17] 国家食品药品监督管理局. 药品检验补充方法和检验项目批准件. 批准件编号2013001降糖类中成药和保健食品[S]. 2013. [18] 国家食品药品监督管理局. 食药监办许(2010). 114号文件附件1辅助降血脂类保健食品违法添加药物的检测方法[S]. 2010. [19] 施亚琴, 姚静, 张启明, 金少鸿. 薄层色谱法快速筛查降血糖中成药及保健食品中添加磺酰脲类化学降糖药[J]. 药物分析杂志, 2007, 27(1): 36-39. https://www.cnki.com.cn/Article/CJFDTOTAL-YWFX200701010.htmSHI Ya-qin, YAO Jing, ZHANG Qi-ming, JIN Shao-hong. TLC method for screening sulphonylureas in antidiabetics Chinese traditional patent medicines and health supplementary foods[J]. Chinese Journal of Pharmaceutical Analysis, 2007, 27(1): 36-39. https://www.cnki.com.cn/Article/CJFDTOTAL-YWFX200701010.htm [20] 张宏莲, 李莉, 许凤, 李静辉, 刘军, 李宏铃. 薄层色谱法检测降糖中药及保健品非法添加的双胍类成分[J]. 科技创新导报, 2013, 10(3): 252-253. doi: 10.3969/j.issn.1674-098X.2013.03.180ZHANG Hong-lian, LI Li, XU Feng, LI Jing-hui, LIU Jun, LI Hong-ling. TLC building of biguanide illegally mixed into hypoglycemic proprietary Chinese medicines and health food[J]. Science and Technology Innovation Herald, 2013, 10(3): 252-253. doi: 10.3969/j.issn.1674-098X.2013.03.180 [21] 曹艳玲. 保健食品中非法添加药物检测技术的应用研究[J]. 食品安全导刊, 2020, 27: 146. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAQ202027093.htmCAO Yan-ling. Research on the application of detection technology of illegally added drugs in health food[J]. China Food Safety Magazine, 2020, 27: 146. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAQ202027093.htm [22] 尚士博, 安康, 何漾, 刘孝泽, 尹龙龙, 张毅. 高效液相色谱法同时测定泡茶中的4种非法添加化学药物[J]. 食品安全质量检测学报, 2018, 9(16): 4296-4301. doi: 10.3969/j.issn.2095-0381.2018.16.018SHANG Shi-bo, AN Kang, HE Yang, LIU Xiao-ze, YIN Long-long, ZHANG Yi. Simultaneous determination of 4 kinds of illegal added of chemical drugs in teabags by high performance liquid chromatography[J]. Journal of Food Safety & Quality, 2018, 9(16): 4296-4301. doi: 10.3969/j.issn.2095-0381.2018.16.018 [23] 李荣, 卫星华, 董靖. HPLC-DAD法测定中成药及保健食品中非法添加16种降糖类化学药物的研究[J]. 辽宁中医杂志, 2018, 45(5): 1022-1024. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201805041.htmLI Rong, WEI Xing-hua, DONG Jing. Determination of 16 anti-diabetic agents illegally added in traditional Chinese medicines and health food by HPLC-DAD[J]. Liaoning Journal of Traditional Chinese Medicine, 2018, 45(5): 1022-1024. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201805041.htm [24] 黎隽, 裴小龙, 张丽, 王一欣. 降糖类中成药和保健食品中13种非法添加成分检测方法改进[J]. 中国药业, 2019, 28(15): 26-29. doi: 10.3969/j.issn.1006-4931.2019.15.009LI Jun, PEI Xiao-long, ZHANG Li, WANG Yi-xin. Improvement of detection method for 13 illegal components added into anti-diabetic Chinese patent medicine and health food[J]. China Pharmaceuticals, 2019, 28(15): 26-29. doi: 10.3969/j.issn.1006-4931.2019.15.009 [25] 刘敏敏, 胡碧波, 陈俏, 林艳. 亚3μm填料核壳技术结合UPLC法快速测定降血脂类中成药及保健食品中12种非法添加物[J]. 中国药师, 2021, 24(2): 379-383. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSG202102040.htmLIU Min-min, HU Bi-bo, CHEN Qiao, LIN Yan. Rapid determination of twelve lipid-lowing illegal additives in traditional Chinese medicine and health food by UPLC coupled with sub-3 μm particle fused-core column[J]. China Pharmacist, 2021, 24(2): 379-383. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSG202102040.htm [26] 陈林, 温家欣, 齐春艳, 雷毅, 张荣. 降压类中成药及保健食品中21种非法添加化学药物的快速检测与确证方法研究[J]. 分析测试学报, 2016, 35(8): 937-942. doi: 10.3969/j.issn.1004-4957.2016.08.002CHEN Lin, WEN Jia-xin, QI Chun-yan, LEI Yi, ZHANG Rong. Rapid detection and conformation of 21 illegal chemical drugs in antihyertension traditional Chinese medicine and healthy food[J]. Journal of Instrumental Analysis, 2016, 35(8): 937-942. doi: 10.3969/j.issn.1004-4957.2016.08.002 [27] 孟丽, 陈伟, 欧阳八四. 液质联用色谱法同时测定降糖类中成药中9种非法添加的化学成分[J]. 中国实验方剂学杂志, 2016, 22(19): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201619014.htmMENG Li, CHEN Wei, OUYANG Ba-si. Simultaneous determination of 9 illegally added anti-diabetic chemical components in Chinese patent medicines by HPLC-MS[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(19): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201619014.htm [28] 覃娟, 谢柏艳, 杨玉平, 王琳, 雷霁远, 彭树翔, 涂林. 液质联用法检测降血糖类保健食品中非法添加的13种化学药物[J]. 食品研究与开发, 2019, 40(19): 192-197. https://www.cnki.com.cn/Article/CJFDTOTAL-SPYK201919041.htmQIN Juan, XIE Bai-yan, YANG Yu-ping, WANG Lin, LEI Ji-yuan, PENG Shu-xiang, TU Lin. Simultaneous determination of 13 kinds of illegal drugs in antidiabetic supplements by HPLC-MS/MS[J]. Food Research and Development, 2019, 40(19): 192-197. https://www.cnki.com.cn/Article/CJFDTOTAL-SPYK201919041.htm [29] 吴俊辉, 罗辉泰, 沈小玲, 黄芳, 胡英杰. HPLC-MS/MS检测中药保健品中非法添加成分的研究[J]. 中药新药与临床药理, 2014, 25(5): 606-610. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY201405022.htmWU Jun-hui, LUO Hui-tai, SHEN Xiao-ling, HUANG Fang, HU Ying-jie. Simultaneous determination of four antidiabetics added to a health-care food illegally by HPLC-MS/MS[J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2014, 25(5): 606-610. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY201405022.htm [30] 郑文燕, 李哲, 陈梅, 谢国丹, 许润娟. LC-MS/MS法检测中成药及保健品中减肥和降糖类的非法添加药物[J]. 沈阳药科大学学报, 2018, 35(1): 58-66, 82. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD201801013.htmZHENG Wen-yan, LI Zhe, CHEN Mei, XIE Guo-dan, XU Run-juan. Determination of anti-obesity and anti-diabetic chemicals illegally added into traditional Chinese medicines and health care products by LC-MS/MS[J]. Journal of Shenyang Pharmaceutical University, 2018, 35(1): 58-66, 82. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD201801013.htm [31] 严华, 张朝晖, 崔凤云, 刘阳晴雪, 齐鹤鸣, 别玮, 梁娜娜, 韩深. 超高效液相色谱-高分辨质谱法检测保健食品中14种降血糖类药物[J]. 食品安全质量检测学报, 2020, 11(3): 815-823. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAJ202003032.htmYAN Hua, ZHANG Zhao-hui, CUI Feng-yun, LIU Yangqingxue, QI He-ming, BIE Wei, LIANG Na-na, HAN Shen. Determination of 14 antidiabetic drugs in health foods by ultra performance liquid chromatography-high resolution mass spectrometry[J]. Journal of Food Safety & Quality, 2020, 11(3): 815-823. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAJ202003032.htm [32] 黄柳倩, 寿林均, 胡磊, 周明昊. HPLC-MS/MS法同时测定三高(高血糖、高血脂、高血压)人群用保健食品中添加的45个化学药物[J]. 药物分析杂志, 2019, 39(3): 484-495. https://www.cnki.com.cn/Article/CJFDTOTAL-YWFX201903016.htmHUANG Liu-qian, SHOU Lin-jun, HU Lei, ZHOU Ming-hao. Simultaneous determination of 45 addition chemical drugs in hyperglycemic, hyperlipidemic and hypertensive People's health foods by HPLC-MS/MS[J]. Chinese Journal of Pharmaceutical Analysis, 2019, 39(3): 484-495. https://www.cnki.com.cn/Article/CJFDTOTAL-YWFX201903016.htm [33] 王琤帅, 舒展, 朱洁, 郑蓝君, 应斌斌. 中成药和保健食品中18种非法添加降压药物的HPLC-QTOF/MS定性检测[J]. 中国药师, 2016, 19(6): 1084-1087. doi: 10.3969/j.issn.1008-049X.2016.06.016WANG Cheng-shuai, SHU Zhan, ZHU Jie, ZHENG Lan-jun, YING Bin-bin. Detection of 18 antihypertensive agents illegally added in traditional Chinese medicines and healthy care products by HPLC-QTOF/MS[J]. China Pharmacist, 2016, 19(6): 1084-1087. doi: 10.3969/j.issn.1008-049X.2016.06.016 [34] 姜春来, 邢俊波, 靳守东. HPLC-Q-TOF法测定降糖类中成药及保健食品中14种非法添加药物[J]. 解放军药学学报, 2016, 32(6): 514-517. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJN201606007.htmJIANG Chun-lai, XING Jun-bo, JIN Shou-dong. Determination of 14 illegally added antidiabetics in traditional Chinese medicines and health care products by performance liquid chromatography-quadrupole/time of flight mass spectrometer[J]. Pharmaceutical Journal of Chinese People's Liberation Army, 2016, 32(6): 514-517. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJN201606007.htm [35] 韩智, 龚蕾, 王会霞, 朱晓玲, 吴婉琴, 刘国姣, 王彬. 轨道离子阱快速筛查及定量分析保健食品中73种非法添加成分[J]. 食品与机械, 2019, 35(7): 74-79, 116. https://www.cnki.com.cn/Article/CJFDTOTAL-SPJX201907014.htmHAN Zhi, GONG Lei, WANG Hui-xia, ZHU Xiao-ling, WU Wan-qin, LIU Guo-jiao, WANG Bin. Rapid screening and quantitative analysis of 73 kinds of chemicals illegally added in the healthy foods by Orbitrap mass spectrometry[J]. Food & Machinery, 2019, 35(7): 74-79, 116. https://www.cnki.com.cn/Article/CJFDTOTAL-SPJX201907014.htm -